RUNX3 and neoplasm: Interestingly, preserved SMAD4 or RUNX3 resulted in similar 5-year DSSs in the tumor epithelial compartment ( 70%), but not in the stromal compartment (SMAD4-/RUNX3+ 80%, SMAD4+/RUNX3- 60%).